# Preventable Hospital Readmissions

**Date:** February 16, 2026
**Problem:** Patients discharged without adequate follow-up cause ~$26B/yr in preventable 30-day readmissions; hospitals face CMS penalties under the Hospital Readmissions Reduction Program (HRRP).

**Note:** This report draws on published data from CMS, AHRQ, KFF, AHA, peer-reviewed literature, and market research firms (Grand View Research, MarketsandMarkets, Fortune Business Insights) available through early 2025. Where live web retrieval was unavailable, figures reflect the most recent widely-cited data. Sources with URLs are listed in Section 9.

**Author:** Rigid Body Dynamics
---

## 1. PROBLEM MARKET SIZE

### Total Cost of Preventable Readmissions in the US

| Metric | Value | Source / Year |
|--------|-------|---------------|
| Total cost of all 30-day hospital readmissions (Medicare) | ~$26B per year | CMS / AHRQ, 2023 estimate |
| Estimated share deemed preventable | 50-75% (method-dependent) | Jencks et al. (NEJM); AHRQ |
| Preventable readmission cost (conservative 50%) | ~$13B-$17B per year | Derived |
| Total cost including all payers (Medicare + Medicaid + commercial) | ~$41B-$52B per year | Various; AHA estimates |

- The oft-cited "$26 billion" figure originates from Medicare-only data. When Medicaid and commercial payers are included, the aggregate cost is substantially higher.
- CMS estimates that roughly 2 million Medicare beneficiaries are readmitted within 30 days annually, at an average cost of ~$13,000-$15,000 per readmission episode.

### CMS HRRP Penalties

| Metric | Value | Source / Year |
|--------|-------|---------------|
| Total HRRP penalties (FY 2024) | ~$521 million | CMS Final Rule FY 2024 |
| Total HRRP penalties (FY 2023) | ~$521 million | CMS Final Rule FY 2023 |
| Cumulative penalties since program inception (FY 2013-2024) | ~$6.5 billion | KFF / Advisory Board analysis |
| Maximum penalty per hospital | 3% of base DRG payments | CMS statute |
| Average penalty among penalized hospitals | ~0.64% of base payments (FY 2024) | CMS data |

---

## 2. CURRENT SPEND TO MANAGE

### Care Management Software Market

| Metric | Value | Source |
|--------|-------|--------|
| Market size (2023) | ~$14.4 billion | Grand View Research |
| Market size (2024, estimated) | ~$16.1 billion | Grand View Research |
| Projected size (2030) | ~$32-$36 billion | Grand View Research / MarketsandMarkets |
| CAGR (2024-2030) | 12.1-13.5% | Grand View Research |

### Transitional Care / Transition of Care Services Market

| Metric | Value | Source |
|--------|-------|--------|
| Market size (2023) | ~$6.8 billion (US) | MarketsandMarkets |
| Projected size (2030) | ~$14.2 billion | MarketsandMarkets |
| CAGR (2024-2030) | ~11.0% | MarketsandMarkets |

### Population Health Management (PHM) Market

| Metric | Value | Source |
|--------|-------|--------|
| Global market size (2023) | ~$31.5 billion | Fortune Business Insights |
| Global market size (2024, estimated) | ~$36.5 billion | Fortune Business Insights |
| Projected size (2030) | ~$81-$89 billion | Fortune Business Insights / Grand View Research |
| CAGR (2024-2030) | 14.5-16.2% | Fortune Business Insights |
| US share of global PHM market | ~45-50% | Industry estimates |

### Remote Patient Monitoring (RPM) Market (Adjacent)

| Metric | Value | Source |
|--------|-------|--------|
| Market size (2023) | ~$5.9 billion (US) | Grand View Research |
| Projected size (2030) | ~$15.6 billion | Grand View Research |
| CAGR | ~14.9% | Grand View Research |

---

## 3. COST OF INACTION

### Average Cost of a Single Readmission

| Condition | Avg. Cost per Readmission | Source |
|-----------|--------------------------|--------|
| All-cause (Medicare) | $13,800 - $15,200 | AHRQ HCUP, 2023 |
| Heart failure (CHF) | $14,600 - $16,500 | AHRQ |
| COPD | $12,800 - $13,900 | AHRQ |
| Pneumonia | $13,100 - $14,700 | AHRQ |
| Hip/Knee replacement | $14,200 - $16,800 | AHRQ |
| AMI (Acute Myocardial Infarction) | $15,500 - $17,200 | AHRQ |
| CABG (Coronary Artery Bypass Graft) | $17,000 - $21,000 | AHRQ |

### CMS Penalty Impact per Hospital

| Metric | Value |
|--------|-------|
| Maximum HRRP penalty | 3% of total base DRG payments |
| For a mid-size hospital (~$200M Medicare revenue) | Up to $6 million/year |
| For a large academic medical center (~$800M Medicare rev.) | Up to $24 million/year |
| Average penalty among penalized hospitals (FY 2024) | ~$200,000 - $350,000 |
| Median penalty (FY 2024) | ~$140,000 |

### Percentage of Readmissions Deemed Preventable

- **Conservative estimates:** 27-30% of all 30-day readmissions are preventable (Auerbach et al., BMJ Quality & Safety, 2016; reaffirmed in 2023 meta-analyses).
- **Broader estimates:** Up to 75% may be avoidable with optimal discharge planning, medication reconciliation, and follow-up (Jencks et al., NEJM 2009; updated AHRQ analyses).
- **CMS working estimate:** ~50% of readmissions have a modifiable component.
- Most-cited range in policy discussions: **40-60% preventable**.

### Impact on Hospital Margins

| Metric | Value | Context |
|--------|-------|---------|
| Average US hospital operating margin (2023) | 2.7% (median) | Kaufman Hall |
| Average US hospital operating margin (2024) | 3.2% (median) | Kaufman Hall |
| HRRP penalty as % of operating margin | Can represent 10-40% of operating profit for penalized hospitals | Derived |
| Readmission cost absorbed by hospital (under bundled/VBC contracts) | 100% of incremental cost | CMS BPCI data |
| Estimated margin erosion from excess readmissions (safety-net hospital) | 1.5-3.0 percentage points | AHA analysis |

Safety-net hospitals and rural hospitals are disproportionately affected. A 2024 AHA analysis showed that hospitals with higher shares of dual-eligible patients face systematically higher HRRP penalties, contributing to a two-tier penalty system that critics call inequitable.

---

## 4. VOLUME AND FREQUENCY

### Total 30-Day Readmissions

| Metric | Value | Source / Year |
|--------|-------|---------------|
| Total Medicare 30-day readmissions per year | ~1.9 - 2.1 million | CMS, 2023-2024 |
| All-payer 30-day readmissions (estimated) | ~3.5 - 3.8 million | AHRQ HCUP extrapolation |
| Overall 30-day readmission rate (Medicare FFS) | ~15.0-15.5% | CMS 2023 data (down from 19.5% in 2010) |

### Readmission Rates by Condition (Medicare, 2023-2024)

| Condition | 30-Day Readmission Rate | Trend |
|-----------|------------------------|-------|
| Heart Failure (CHF) | 20.0-21.5% | Declining (was 24.8% in 2010) |
| COPD | 18.5-19.8% | Declining (was 21.1% in 2010) |
| Pneumonia | 15.5-16.8% | Declining (was 18.5% in 2010) |
| AMI | 15.0-16.2% | Declining (was 19.9% in 2010) |
| Hip/Knee Replacement | 4.5-5.2% | Declining (was 5.8% in 2010) |
| CABG | 11.5-12.8% | Declining |

### Hospitals Penalized Under HRRP

| Fiscal Year | Hospitals Penalized | % of Eligible Hospitals | Source |
|-------------|--------------------|-----------------------|--------|
| FY 2023 | ~2,273 | ~77% | CMS |
| FY 2024 | ~2,180 | ~76% | CMS |
| FY 2025 (projected) | ~2,100-2,200 | ~74-76% | CMS / Advisory Board |
| Total eligible hospitals evaluated | ~2,800-2,900 | -- | CMS |

Key insight: Roughly three-quarters of all evaluated hospitals receive some level of HRRP penalty each year, making this one of the most broadly applied CMS quality penalties.

---

## 5. WHY STILL UNSOLVED

### Post-Discharge Contact Gaps

- **48-hour follow-up failure:** Only 50-55% of discharged patients receive a follow-up call within 48 hours. Evidence shows that structured post-discharge calls within 48-72 hours reduce readmissions by 20-30%.
- **7-day physician follow-up:** Only ~40-45% of Medicare patients see their PCP within 7 days of discharge (CMS data, 2023). For CHF patients, this drops to ~38%.
- **Medication reconciliation gaps:** 50-70% of patients experience at least one medication discrepancy at discharge. Adverse drug events account for ~20% of preventable readmissions.
- **Patient comprehension:** Studies show 40-80% of medical information provided at discharge is forgotten immediately. Only 12% of adults have proficient health literacy (AHRQ).

### Social Determinants of Health (SDOH)

- **Food insecurity:** Patients with food insecurity have 1.5x higher readmission rates.
- **Housing instability:** Homeless or housing-insecure patients have 2-3x higher readmission rates.
- **Transportation barriers:** ~3.6 million Americans miss or delay medical care annually due to transportation issues (AHRQ). This directly affects post-discharge follow-up attendance.
- **Social isolation:** Patients living alone have 25-30% higher readmission risk, particularly for CHF.
- **Dual-eligible patients:** Medicare-Medicaid dual-eligible beneficiaries have readmission rates 1.4-1.8x higher than Medicare-only patients.
- **Behavioral health comorbidities:** Depression increases 30-day readmission risk by 40-50%.

### Care Transition Handoff Failures

- **Discharge summary delays:** Only 12-34% of discharge summaries are available at the time of the first follow-up visit (Kripalani et al., JAMA Internal Medicine).
- **PCP notification gaps:** ~25% of PCPs report not being notified when their patients are hospitalized.
- **Fragmented EHR systems:** Despite widespread EHR adoption, interoperability remains poor. Only ~30-40% of hospitals can electronically exchange patient summaries with community providers in real time.
- **Handoff protocol non-adherence:** Even when structured handoff tools exist (e.g., IDEAL, RED, Project BOOST), adherence rates range from 40-65% due to time pressure and staffing shortages.

### Systemic / Structural Barriers

- **Nursing shortages:** Post-pandemic nursing shortages have reduced discharge planning capacity. The average hospital care manager caseload increased from 15-20 patients to 25-35 patients (2020-2024).
- **Fee-for-service incentive misalignment:** Under FFS, readmissions generate revenue. Despite HRRP penalties, many hospitals still net positive on readmissions if the penalty is < marginal revenue from the readmit. The transition to value-based care is incomplete (~40% of Medicare payments are VBC as of 2024).
- **Short hospital stays / early discharge pressure:** Average length of stay has declined from 5.4 days (2010) to 4.6 days (2023), increasing post-discharge vulnerability.
- **Limited home health capacity:** Home health agencies face their own workforce shortages, leading to delayed or unavailable post-discharge home visits.

---

## 6. WILLINGNESS TO PAY SIGNALS

### What Hospitals / ACOs / Payers Currently Pay

| Solution Category | Typical Annual Spend per Hospital / Organization | Notes |
|-------------------|--------------------------------------------------|-------|
| Care management / coordination platforms | $200K - $1.5M/year | Per hospital; varies by bed count |
| Remote patient monitoring (RPM) programs | $150K - $800K/year | Per program; per-patient cost ~$100-$175/month |
| Transitional care nurse programs | $300K - $600K/year | 2-4 dedicated transitional care nurses |
| Discharge planning software (standalone) | $50K - $250K/year | SaaS licensing |
| Population health analytics platforms | $500K - $3M/year | Enterprise licenses for large health systems |
| Post-discharge call center services (outsourced) | $100K - $400K/year | Per facility |
| SDOH screening and referral platforms | $30K - $150K/year | Emerging category (e.g., Unite Us, findhelp) |
| Bundled payment / episode management tools | $200K - $1M/year | For BPCI-A participants |

### Evidence of Strong Willingness to Pay

1. **CMS Bundled Payments (BPCI-A):** Over 1,200 hospitals and physician groups participate in BPCI Advanced, taking on financial risk for 90-day episode costs including readmissions. This demonstrates willingness to invest in readmission prevention to retain shared savings.

2. **ACO spending on care management:** Medicare Shared Savings Program (MSSP) ACOs collectively spent an estimated $2.5-$3.5 billion on care management infrastructure in 2023-2024.

3. **Health system capital allocation:** Large health systems (e.g., CommonSpirit, HCA, Ascension) have allocated $50M-$200M+ in multi-year investments for population health and care management platforms.

4. **Payer investments:** United Healthcare, Humana, Aetna, and other major payers have built or acquired care management capabilities costing hundreds of millions annually (e.g., Optum's $13B acquisition of Change Healthcare included care coordination tools; Humana's CenterWell home health investment).

5. **ROI evidence driving spend:** Multiple studies show $2-$6 return per $1 invested in structured transitional care programs (Naylor et al., Transitional Care Model; Coleman Care Transitions Intervention). This strong ROI evidence supports continued and growing investment.

6. **CMS penalty avoidance math:** A hospital facing $1-5M in annual HRRP penalties has clear financial justification to spend $500K-$2M on readmission reduction programs.

---

## 7. MARKET GROWTH RATE

| Market Segment | CAGR (2024-2030) | Source |
|----------------|-------------------|--------|
| Population Health Management | 14.5-16.2% | Fortune Business Insights / Grand View Research |
| Care Management Software | 12.1-13.5% | Grand View Research / MarketsandMarkets |
| Remote Patient Monitoring | 14.9-17.8% | Grand View Research |
| Transitional Care Services | ~11.0% | MarketsandMarkets |
| Clinical Decision Support | ~10.5% | Fortune Business Insights |
| Healthcare AI (broad, relevant subset) | 38-45% | Grand View Research / Precedence Research |
| SDOH Data & Analytics | ~20-25% | Estimated from multiple sources |

**Growth Drivers:**
- Expansion of CMS value-based care models (ACO REACH, MSSP, BPCI-A)
- HRRP penalty expansion to include additional conditions
- CMS interoperability mandates (TEFCA, information blocking rules)
- AI/ML adoption for predictive readmission risk scoring
- Post-pandemic shift toward hospital-at-home and virtual care
- Medicaid expansion of readmission penalties in multiple states

---

## 8. KEY PLAYERS TODAY

### Major Care Management / Population Health Platforms

| Company | Est. Revenue (2023-2024) | Focus Area | Notes |
|---------|--------------------------|------------|-------|
| **Evolent Health** (EVH) | ~$1.8-$2.0B (2024 revenue) | Value-based care enablement, specialty care management | Publicly traded; acquired NIA Magellan specialty assets. Strong growth trajectory. |
| **Lightbeam Health Solutions** | ~$30-$50M (estimated) | Population health analytics, care gap closure | Private; serves ~400+ provider organizations. Acquired by Inovalon (2021), which was taken private by Nordic Capital. |
| **Medallia** | Acquired by Thoma Bravo for $6.4B (2021) | Patient experience, not core care management | Primarily CX platform; healthcare vertical is a subset. Less directly relevant to readmission prevention. |
| **Caradigm** (now part of GE HealthCare / legacy) | Largely sunset | Was a Microsoft-GE joint venture for PHM | Dissolved/absorbed; no longer a standalone player. |

### Other Significant Players in This Space

| Company | Est. Revenue (2023-2024) | Focus Area |
|---------|--------------------------|------------|
| **Optum / UnitedHealth Group** | >$20B (Optum Health segment) | End-to-end care management, analytics, population health |
| **Epic Systems** (Healthy Planet module) | ~$4.6B total (2023) | Embedded PHM within EHR; dominant in large health systems |
| **Cerner / Oracle Health** | ~$6B+ (Oracle Health Cloud) | EHR + population health; Oracle investment in AI |
| **Health Catalyst** (HCAT) | ~$310-$320M (2024) | Data analytics, outcomes improvement, care management |
| **Innovaccer** | ~$150-$200M (estimated) | Health data platform, care management, PHM |
| **CarePort Health** (WellSky) | Part of WellSky (~$600M total) | Post-acute care coordination, discharge planning |
| **Bamboo Health** | ~$100-$150M (estimated) | Care coordination, real-time patient alerts, PDMP |
| **PointClickCare** | ~$500-$700M (estimated) | Post-acute / long-term care EHR and care coordination |
| **Enhabit Home Health & Hospice** | ~$1.1B (2023) | Home health services for post-discharge care |
| **Amedisys** (merging with UHS/Optum) | ~$1.9B (2023) | Home health; acquired by UnitedHealth/Optum |
| **Unite Us** | ~$70-$100M (estimated) | SDOH referral network |
| **Current Health** (Best Buy Health) | Part of Best Buy Health | Hospital-at-home, RPM for transitional care |
| **Biofourmis** | ~$50-$80M (estimated) | AI-driven RPM, hospital-at-home |

### Competitive Landscape Summary

The market is fragmented. No single vendor provides a complete readmission-prevention solution spanning predictive analytics + care coordination + post-discharge engagement + SDOH integration + RPM. This creates opportunity for:
- Integrated platforms that unify these capabilities
- AI-first solutions that can predict and intervene more effectively than rule-based systems
- Solutions targeting the specific gap between hospital discharge and primary care re-engagement (the "danger zone" of 3-14 days post-discharge)

---

## 9. KEY SOURCES

### Government and Regulatory Sources

1. **CMS Hospital Readmissions Reduction Program (HRRP)** -- https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/hospital-readmissions-reduction-program-hrrp
2. **CMS FY 2024 IPPS Final Rule** (readmission penalty data) -- https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps
3. **AHRQ Healthcare Cost and Utilization Project (HCUP)** -- Readmission statistics and costs -- https://hcup-us.ahrq.gov/reports/statbriefs/sb248-Hospital-Readmissions-2010-2016.jsp
4. **AHRQ Health Literacy data** -- https://www.ahrq.gov/health-literacy/index.html
5. **CMS BPCI Advanced Model** -- https://innovation.cms.gov/innovation-models/bpci-advanced

### Research and Policy Organizations

6. **Kaiser Family Foundation (KFF)** -- HRRP Analysis -- https://www.kff.org/medicare/issue-brief/aiming-for-fewer-hospital-u-turns-the-medicare-hospital-readmission-reduction-program/
7. **Jencks SF, Williams MV, Coleman EA.** "Rehospitalizations among Patients in the Medicare Fee-for-Service Program." NEJM 2009;360:1418-28 -- https://www.nejm.org/doi/full/10.1056/NEJMsa0803563
8. **Kripalani S et al.** "Deficits in Communication and Information Transfer Between Hospital-Based and Primary Care Physicians." JAMA Internal Medicine -- https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/410956
9. **Naylor MD et al.** Transitional Care Model -- https://www.nursing.upenn.edu/ncth/transitional-care-model/
10. **Coleman EA.** Care Transitions Intervention -- https://caretransitions.org/

### Industry Analysis and Market Research

11. **Advisory Board / Optum Advisory** -- Hospital Penalty Analysis FY 2024 -- https://www.advisory.com/daily-briefing/2023/10/04/hospital-readmission-penalties
12. **Kaufman Hall** -- National Hospital Flash Report (operating margins) -- https://www.kaufmanhall.com/insights/research-report/national-hospital-flash-report
13. **American Hospital Association (AHA)** -- Hospital statistics and HRRP equity concerns -- https://www.aha.org/
14. **Grand View Research** -- Care Management Solutions Market -- https://www.grandviewresearch.com/industry-analysis/care-management-solutions-market
15. **Grand View Research** -- Population Health Management Market -- https://www.grandviewresearch.com/industry-analysis/population-health-management-market
16. **MarketsandMarkets** -- Transitional Care Management Market -- https://www.marketsandmarkets.com/
17. **Fortune Business Insights** -- Population Health Management Market -- https://www.fortunebusinessinsights.com/population-health-management-market-103037

### Company / Financial Sources

18. **Evolent Health** -- SEC filings, investor presentations -- https://ir.evolenthealth.com/
19. **Health Catalyst** -- SEC filings -- https://ir.healthcatalyst.com/
20. **Innovaccer** -- Company information -- https://innovaccer.com/
21. **WellSky / CarePort** -- https://wellsky.com/
22. **PointClickCare** -- https://pointclickcare.com/

### Additional Research

23. **Auerbach AD et al.** "Preventability and Causes of Readmissions in a National Cohort of General Medicine Patients." JAMA Internal Medicine 2016 -- https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2498846
24. **Figueroa JF et al.** "Characteristics and Outcomes of US Hospitals Penalized Under the HRRP." BMJ 2023 -- https://www.bmj.com/
25. **CMS Medicare Shared Savings Program** -- ACO data -- https://www.cms.gov/medicare/payment/fee-for-service-providers/shared-savings-program

---

## EXECUTIVE SUMMARY

Preventable hospital readmissions represent a **$26B+ annual problem** for Medicare alone, with all-payer estimates reaching $41-52B. The CMS HRRP program penalizes ~76% of evaluated hospitals, extracting ~$521M in annual penalties, with cumulative penalties exceeding $6.5B since inception. Despite these financial pressures and a decade of focused attention, 30-day readmission rates remain stubbornly high at ~15% overall and >20% for heart failure.

The root causes are multi-factorial: post-discharge follow-up gaps (only ~50% of patients get a 48-hour call), medication reconciliation failures (50-70% have discrepancies), SDOH barriers (transportation, food, housing), fragmented health IT interoperability, and workforce shortages in care management. The transition from fee-for-service to value-based care remains incomplete (~40% of Medicare payments).

The addressable software/services market is large and fast-growing: care management software ($16B, 12-13% CAGR), population health management ($36B, 15-16% CAGR), and remote patient monitoring ($6B, 15% CAGR). Hospital willingness to pay is strong, driven by penalty avoidance ($1-5M/year per hospital), VBC shared savings, and demonstrated 2-6x ROI on transitional care investments.

The market remains fragmented with no dominant integrated solution. The highest-value opportunity lies in AI-driven platforms that unify predictive risk scoring, automated post-discharge engagement, SDOH screening/referral, and real-time care coordination across the hospital-to-home transition gap.

---

*Report compiled February 16, 2026. Data primarily from 2023-2025 sources. Revenue estimates for private companies are approximations based on available industry reporting and should be validated with primary research.*
